Every new New York filing, every dayCrossbow Therapeutics is a biotechnology company developing novel antibody therapeutics for cancer treatment, with a focus on TCR-mimetic antibodies. The website describes their mission to expand the reach of antibody therapies. The company has raised $77 million in Series B financing as reported in recent news.
Filed April 30, 2025 · Manhattan, NY
Your competitors in Manhattan are getting unlimited new business leads.

Every new New York filing, every day
See how it worksCrossbow Therapeutics is a biotechnology business (Corp) registered on April 30, 2025 with the New York Division of Corporations. The business is located in Manhattan, New York 122072543.
New verified leads every morning, and an AI-built email campaign ready to go. We build it, you hit send.
Build My Campaign Free ›We matched this business to its website and pulled the domain's registration (WHOIS) record. Domain age is one of the strongest signals that a filing is a truly new business and not a re-filing or paperwork change.
Filing timeline will be available soon.
Crossbow Therapeutics was registered as Corp on April 30, 2025 in New York.
Crossbow Therapeutics is based in Manhattan, NY, 122072543.
Crossbow Therapeutics is classified as a biotechnology business (antibody therapeutics).
No EIN was found on file for Crossbow Therapeutics at the time of registration.
Based on the business category, these service providers typically target this type of business.